New RNA drug aims to reduce blood removal in polycythemia vera patients
Disease control
Ongoing
This study tests a new drug called SLN124 in 69 adults with polycythemia vera, a condition where the body makes too many red blood cells. The drug works by blocking a protein that controls iron use, which may lower red blood cell production and reduce the need for regular blood r…
Phase: PHASE1, PHASE2 • Sponsor: Silence Therapeutics plc • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC